Results 51 to 60 of about 30,777 (214)

Impact of Femoropopliteal Drug‐Coated Balloon Use on Clinical Outcomes in Patients With Chronic Limb‐Threatening Ischemia

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloons (DCBs) for femoropopliteal (FP) lesions have demonstrated superiority over standard percutaneous transluminal angioplasty (PTA) in maintaining vessel patency. However, data on whether the good durability of DCBs translates into improved wound outcome in chronic limb‐threatening ischemia (CLTI) patients are ...
Haruya Yamane, Yosuke Hata, Osamu Iida, Yasunori Ueda, Kuniyasu Ikeoka, Taku Toyoshima, Motoki Yasunaga, Hiroaki Nohara, Akito Kawamura, Sho Nakao, Yohei Sotomi, Yasushi Sakata   +11 more
wiley   +1 more source

Pentoxifylline for intermittent claudication [PDF]

Cochrane Database of Systematic Reviews, 2015
Intermittent claudication (IC) is a symptom of peripheral arterial disease (PAD) and is associated with high morbidity and mortality. Pentoxifylline, one of many drugs used to treat IC, acts by decreasing blood viscosity, improving erythrocyte flexibility and promoting microcirculatory flow and tissue oxygen concentration.
Kareem Salhiyyah, Eshan Senanayake, Mohammed Abdel-Hadi, Rachel Forster, Jonathan Michaels, Andrew Booth   +5 more
openaire   +4 more sources

Peripheral Arterial Disease Prevalence in a Population-Based Sample of People with Diabetes on the Caribbean Island of Barbados

Vascular Health and Risk Management, 2022
O Peter Adams,1 Joseph R Herbert,1 Nigel Unwin,2– 4 Christina Howitt2 1Faculty of Medical Sciences, University of the West Indies, Cave Hill Campus, St Michael, Barbados; 2George Alleyne Chronic Disease Research Centre, University of the West Indies, St.
Adams OP, Herbert JR, Unwin N, Howitt C
doaj  

Patient Characteristics and Comorbidities Influence Walking Distances in Symptomatic Peripheral Arterial Disease: A Large One-Year Physiotherapy Cohort Study. [PDF]

PLoS ONE, 2016
OBJECTIVES:The aim of this study is to investigate the association between age, gender, body-mass index, smoking behavior, orthopedic comorbidity, neurologic comorbidity, cardiac comorbidity, vascular comorbidity, pulmonic comorbidity, internal ...
Sarah Dörenkamp, Ilse Mesters, Rob de Bie, Joep Teijink, Gerard van Breukelen   +4 more
doaj   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

A systematic review and meta‐analysis of randomized controlled trials on the effects of internal iliac artery balloon occlusion in placenta previa and placenta accreta spectrum in reducing perioperative bleeding

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Preoperative prophylactic balloon occlusion (PPBO) of internal iliac arteries (IIAs) in placenta previa and placenta accreta spectrum (PAS) has been widely used as a preventive adjuvant technique to reduce blood loss and to preserve fertility. Nevertheless, the efficacy of PPBO is based primarily on retrospective studies.
Rula Iskander, Manal Massalha, Chen Remer, Ido Izhaki, Raed Salim   +4 more
wiley   +1 more source

Rivaroxaban with Aspirin Versus Aspirin for Peripheral Arterial Disease and Intermittent Claudication. Rationale and Design of the COMPASS CLAUDICATION Trial

Clinical and Applied Thrombosis/Hemostasis, 2022
Background The COMPASS trial demonstrated that in patients with peripheral arterial disease, the combination of rivaroxaban and aspirin compared with aspirin reduces the risk of major adverse limb events, but it is not known whether this combination can ...
Eduardo Ramacciotti MD, PhD, Leandro Barile Agati PhD, Giuliano Giova Volpiani MD, Karen Falcão Brito MD, Camilla Moreira Ribeiro PhD, Valéria Cristina Resende Aguiar MD, Lorenzo Storino Ramacciotti, Alexia Paganotti, Felipe Menegueti Pereira, Roberto Augusto Caffaro MD, PhD, Alexandre Fioranelli MD, PhD, Rogério Krakauer MD, Heron Rhydan Saad Rached, Nelson Wolosker MD, PhD, Sonia S. Anand MD, John W. Eikelboom MBBS, Renato Delascio Lopes MD, PhD   +16 more
doaj   +1 more source

Macrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration

Cell Proliferation, EarlyView.
Macrophages, integral to degenerated intervertebral discs, play a critical role in disc degeneration. By performing efferocytosis, they clear apoptotic cells. This article explores the process of efferocytosis, its molecular mechanisms, potential therapeutic implications for intervertebral disc degeneration and future strategies for targeted treatments.
Shijie Chen, Haijun Zhang, Zhaoheng Wang, Daxue Zhu, Yanhu Li, Yizhi Zhang, Dongxin Wang, Shuwei Chen, Huan Liu, Xuewen Kang   +9 more
wiley   +1 more source

Entrapped Crown of Orbital Atherectomy Device by Intimal Tissue Entanglement During Peripheral Intervention

JACC: Case Reports, 2021
Orbital atherectomy is a commonly used procedure for peripheral arterial disease. Crown entrapment is a rare but potentially dangerous complication of orbital atherectomy.
Aditya D. Hendrani, MD, Theresia R. Davita, MD, Daniel Morcos, Gautam Pathak, Ehab Morcos, MD   +4 more
doaj  

Long‐term efficacy of autologous cell therapy, repeated PTA and conservative treatment in people with diabetes and chronic limb‐threatening ischaemia

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Data about long‐term clinical outcomes of revascularization procedures, especially for autologous cell therapy (ACT), in diabetic patients with chronic limb‐threatening ischaemia (CLTI) are lacking. The aim of our study was to compare the mortality and amputation rates in patients with diabetic foot ulcers (DFU) and CLTI treated by ACT ...
M. Dubský, D. Sojáková, J. Husáková, A. Němcová, V. Fejfarová, R. Jarošíková, V. Frelichová, K. Sutoris, E. B. Jude   +8 more
wiley   +1 more source